Clinical and Pathological Characteristics of Stage IV SMARCA4-Deficient Lung Cancer and the Efficacy of Immune Checkpoint Inhibitors
{{output}}
Aims: The aim of this study was to investigate clinicopathological characteristics and immune checkpoint inhibitor (ICI) efficacy in stage IV SMARCA4-deficient lung cancer. ... ...
